Ethanamine,2-[(4-chlorophenyl)-2-pyridinylmethoxy]-N,N-dimethyl- (486-16-8)

Identification
Name:	Ethanamine,2-[(4-chlorophenyl)-2-pyridinylmethoxy]-N,N-dimethyl-
CAS:	486-16-8
EINECS:	207-628-6
Molecular Formula:	C16H19 Cl N2 O
Molecular Weight:	290.78786
InChI:	InChI=1/C16H19ClN2O/c1-19(2)11-12-20-16(15-5-3-4-10-18-15)13-6-8-14(17)9-7-13/h3-10,16H,11-12H2,1-2H3
Molecular Structure:
Properties
Flash Point:	184.3°C
Boiling Point:	381.1°Cat760mmHg
Density:	1.143g/cm³
Specification:	Carbinoxamine (CAS NO.486-16-8), its Synonyms are (+-)-Carbinoxamine ; 2-(p-Chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine ; Allergefon ; Carbinoxamina ; Carbinoxaminum ; McN-R 73Z ; Paracarbinoxamine ; Ethanamine, 2-((4-chlorophenyl)-2-pyridinylmethoxy)-N,N-dimethyl- (9CI) ; N,N-Dimethyl-2-(p-chloro-alpha-(2-pyridyl)benzyloxy)ethylamine ; Pyridine, 2-(p-chloro-alpha-(2-(dimethylamino)ethoxy)benzyl . It is antihistamine and anticholinergic. Carbinoxamine is approved by the U.S. Food and Drug Administration (FDA) for hay fever (a.k.a. allergic rhinitis, SAR and PAR); vasomotor rhinitis; mild urticaria; angioedema, dermatographism and allergic conjunctivitis. At present, all carbinoxamine-containing formulations are approved only for adults or children ages 3 or older.
Flash Point:	184.3°C
Safety Data